Therefore, it is possible that inhibiting the activity of downstream signallings by IL‐38 may cause less inflammatory component generation in PBMCs during inflammatory response, which will further result in inhibition of dysregulated immunity, and prevent development of lupus. The gene discussed is IL1F10; the disease is systemic lupus erythematosus.